American journal of hematology 2023 Aug 24
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
Related Questions
Data is still lacking regarding a possible synergistic effect with radiation and TKI. Would you be concerned that this would cause more side effects t...
New comment by Radiation Oncologist at Memorial Sloan Kettering Cancer Center ( February 10, 2025)
To this point, an important question to ask is about competing risks. If this is a man with favorable intermediate-risk prostate cancer and metastatic RCC, does active surveil...